- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06704282
Assessing the Impact of VR-Based Observational Mindfulness Meditation on Stress Reduction in Adults (VR-MOM)
Effects of VR-Based Mindfulness Observational Meditation for Stress Reduction in Adults : Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study employs a randomized controlled design to assess the effectiveness of a VR-based mindfulness intervention for stress reduction. Participants are randomly assigned to either the experimental group, which undergoes VR-based observation mindfulness activities guided by an AI coach, or the control group, which experiences standard relaxation exercises. Pre-intervention data, including self-reported stress levels (measured via PSS-10, DASS-21, and STAI) and baseline heart rate, are collected. Following the intervention, participants complete post-intervention measurements to evaluate changes in stress levels, physiological responses, and satisfaction with the VR program.
The experimental group participates in mindfulness activities designed to enhance attention to detail and present-moment awareness through object observation within the VR environment. The AI coach facilitates the session by prompting reflective and observational questions, fostering deeper engagement. The control group undergoes relaxation exercises with no active mindfulness engagement. All procedures are conducted in a controlled laboratory setting, ensuring consistency and minimizing external variables.
The study collects objective (heart rate and heart rate variability) and subjective (self-reported stress and satisfaction) data to evaluate the intervention's efficacy. The findings aim to provide insights into the feasibility and benefits of integrating VR and AI technologies in stress reduction interventions. The results will also contribute to the development of more engaging and accessible digital mindfulness practices for diverse populations.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
Erie, Pennsylvania, United States, 16563
- Penn State Univercity
-
Contact:
- Jiheun Hong, Master
- Phone Number: 630-877-7467
- Email: jbh6626@psu.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adults aged 18 years and older.
Exclusion Criteria:
- Those with visual or hearing impairments that prevent interaction with VR content.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Mindfulness Meditation Group
Participants in this arm will undergo a 15-minute VR-based mindfulness observational meditation session guided by a virtual coach.
The intervention focuses on promoting mindfulness and reducing stress through structured guidance in a controlled virtual environment.
|
A 15-minute guided mindfulness meditation session conducted in a virtual reality environment to enhance stress reduction and mindfulness.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Reduction in Perceived Stress Levels
Time Frame: Immediately post-intervention (Day 1, 15 minutes after the session ends).
|
Changes in perceived stress levels measured using the Perceived Stress Scale (PSS-10) to assess the effectiveness of the VR-based mindfulness observational meditation intervention.
|
Immediately post-intervention (Day 1, 15 minutes after the session ends).
|
|
Changes in Emotional State
Time Frame: Immediately post-intervention (Day 1, 15 minutes after the session ends).
|
Emotional state assessed using the Depression Anxiety Stress Scales (DASS-21) and the State-Trait Anxiety Inventory (STAI).
These indicators will be evaluated pre- and post-intervention to measure reductions in anxiety and overall emotional improvement.
|
Immediately post-intervention (Day 1, 15 minutes after the session ends).
|
|
Participant Satisfaction with Intervention
Time Frame: Immediately post-intervention (Day 1).
|
Participant satisfaction assessed via a structured satisfaction survey post-intervention, including feedback on usability, perceived effectiveness, and comfort with the VR program.
|
Immediately post-intervention (Day 1).
|
|
Physiological Stress Response
Time Frame: Baseline (before intervention) and immediately post-intervention (Day 1).
|
Heart rate measured pre- and post-intervention using a heart rate monitor to assess changes in physiological stress levels as a biomarker.
|
Baseline (before intervention) and immediately post-intervention (Day 1).
|
|
Changes in Emotional State Using STAI
Time Frame: Baseline (prior to intervention) and immediately post-intervention (Day 1, 15 minutes after the session ends).
|
Anxiety levels will be assessed using the State-Trait Anxiety Inventory (STAI), which measures both state and trait anxiety components.
The STAI-S (State Anxiety) evaluates participants' current feelings, while the STAI-T (Trait Anxiety) measures participants' general tendencies toward anxiety.
Measurements will be taken pre- and post-intervention to evaluate reductions in anxiety.
|
Baseline (prior to intervention) and immediately post-intervention (Day 1, 15 minutes after the session ends).
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00025978
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of CincinnatiNational Center for Complementary and Integrative Health (NCCIH)RecruitingMild DepressionUnited States
-
University of MinnesotaCompletedDepression SymptomsUnited States
Clinical Trials on VR Mindfulness Meditation Program
-
Cyprus Aydin UniversityRecruitingStress | Hemodialysis | Sleep Quality | SymptomCyprus
-
Weill Medical College of Cornell UniversityAvon FoundationCompletedBreast CancerUnited States
-
Weill Medical College of Cornell UniversityAvon FoundationCompletedGynecologic Cancer | Breast CancersUnited States
-
Kutahya Health Sciences UniversityKoç UniversityCompleted
-
Weill Medical College of Cornell UniversityBrain & Behavior Research FoundationCompletedAnxiety | Distress, EmotionalUnited States
-
Ospedale Regionale di MendrisioRecruitingAnxiety State | Test Anxiety | Preoperative PeriodSwitzerland
-
University of Wisconsin, MadisonChan Zuckerberg Initiative; Healthy Minds Innovations; Center for Healthy MindsCompletedDepression | Anxiety | Psychological Distress | Well-being | Psychological StressUnited States
-
Yale UniversityFriends of Yale New Haven Children's HospitalCompletedPediatric ObesityUnited States
-
Medical University of South CarolinaNational Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular Diseases | HypertensionUnited States
-
University of UtahNational Center for Complementary and Integrative Health (NCCIH)Completed